Fairvalue-Calculator Fairvalue-Calculator
EN DE

Cannara Biotech Inc (LOVFF) Fair Value & Analysis

Healthcare · US · Market cap $114M

Price$1.16
Fair Value$2.05
Upside+76.7%
Quality95/100
Evidence: High Range $1.37 – $2.56

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Cannara Biotech Inc (LOVFF) currently trades at $1.16, while our model-based Fair Value estimate is $2.05 — implying the stock looks roughly 76.7% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +885% Jiangsu Hengrui Pharmaceuticals Co (600276) -44% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -75% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -78%

Frequently asked questions

Is Cannara Biotech Inc (LOVFF) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $2.05 versus a price of $1.16 — about +77% (undervalued). Model-based estimate, not financial advice.
What is the fair value of LOVFF?
Our 21-model fair value for Cannara Biotech Inc is $2.05 (as of Jun 24, 2026), built from audited fundamentals. The current price is $1.16.
What is the quality score of LOVFF?
Cannara Biotech Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.